A biomarker is a measurable indicator associated with changes in physiological state or disease. In contrast to the blood which is under homeostatic controls, urine reflects changes in the body earlier and more sensitively, and is therefore a better biomarker source. Lysine acetylation is an abundant and highly regulated post-translational modification. It plays a pivotal role in modulating diverse biological processes and is associated with various important diseases. Enrichment or visualization of proteins with specific post-translational modifications provides a method for sampling the urinary proteome and reducing sample complexity. In this study, we used anti-acetyllysine antibody-based immunoaffinity enrichment combined with high-resolution mass spectrometry to profile lysine-acetylated proteins in normal human urine. A total of 629 acetylation sites on 315 proteins were identified, including some very low-abundance proteins. This is the first proteome-wide characterization of lysine acetylation proteins in normal human urine. Our dataset provides a useful resource for the further discovery of lysine-acetylated proteins as biomarkers in urine.
INTRODUCTION
A biomarker is a measurable change associated with a physiological or pathophysiological process (Gao, 2013) . In contrast to the blood, which is controlled by homeostatic mechanisms, urine as a waste product, accumulates changes. Urine is an attractive resource for early and sensitive biomarker discover (Gao, 2013; Li et al., 2014) . In addition, urine can be easily and non-invasively collected in large quantities and does not undergo significant proteolytic degradation compared to other biofluids (Decramer et al., 2008) . We established a urimem that adsorbs biological molecules in the urine onto a membrane (Jia et al., 2014; Zhang et al., 2015) . This method makes it possible to store and archive urine samples economically on a large scale for long-term preservation. Urine may become very important for large-scale biomarker research.
Post-translational modifications (PTMs) are covalent modifications of a protein (Mann and Jensen, 2003) and play a vital role in modulating many biological functions. In the past decade, the evolution of mass spectrometry (MS)-based proteomic methods including enrichment strategies has enabled wide-scale identification of PTMs, such as acetylation (Kim et al., 2006) , glycosylation (Wang et al., 2006) , and phosphorylation (Olsen et al., 2006) . Lysine acetylation (Kac), a dynamic and reversible PTM, was initially discovered in histones approximately 50 years ago (Vidali et al., 1968) . Subsequent studies were focused on chromatin remodeling for gene transcription, until the first non-histone protein, p53, was identified to be lysine-acetylated (Gu and Roeder, 1997) . The first systematic analysis of lysineacetylated proteins, indicating that Kac is involved in the regulation of diverse cellular pathways beyond DNA-templated processes was reported by Kim et al. (2006) . Subsequent studies detected abundant Kac in non-histone proteins in eukaryotes (such as in human, mouse, and Drosophila) (Choudhary et al., 2009; Kim et al., 2006; Yu et al., 2009 ) and prokaryotes (such as Escherichia coli, Salmonella enterica) (Wang et al., 2010; Zhang et al., 2009 ). Lysineacetylated proteins are involved in nearly all cellular processes and are evolutionarily conserved from bacteria to mammals. These proteins are also associated with important diseases such as metabolic diseases, neurodegenerative disorders, and cardiovascular diseases (Menzies et al., 2016; Pons et al., 2009; Voelter-Mahlknecht, 2016; Zhao et al., 2010) .
In urine, only glycosylation and phosphorylation have been studied and applied in biomarker research Wang et al., 2006) . Compared to more than 400 forms of PTMs detected in proteins (Rotilio et al., 2012) , little is known about the PTMs of urine proteins. In this study, we used immunoaffinity-based acetyllysine peptide enrichment integrated with high-resolution MS to profile lysine-acetylated proteins in normal human urine.
RESULTS

Western blot analysis of lysine-acetylated urinary proteins of healthy humans
In order to explore the status of lysine acetylation in the urine proteome of healthy humans, Western blot analysis was performed using a pan anti-acetyllysine antibody. The results showed that multiple protein bands with a wide range of molecular weights were detected. In addition to histones (11-15 kD and 26 kD), many non-histone proteins with clear bands were observed ( Figure 1B and Figure S1 in Supporting Information), indicating that lysine acetylation is highly abundant in human urine.
Profiling of lysine-acetylated urinary proteins
Because lysine acetylation plays a vital role in modulating various molecular processes and widely exists in the urine, we comprehensively profiled lysine-acetylated proteins in the urine. Pooled first morning mid-stream urine (3 males and 3 females, aged 24-30 years) was used for further immunoaffinity-based acetyllysine peptide enrichment and LC-MS/MS analysis.
We first identified 761 acetylated peptides (Peptide-spectrum matches false-discovery rate (FDR)<0.1%) (Table S1 in Supporting Information) matched on 315 lysine-acetylated proteins (Unique peptides≥1) with 629 Kac sites (AS-core≥59) in normal human urine (Table S2 in Supporting Information). Among these proteins, 18 contained five or more Kac sites, accounting for 5.7% of the total detected Kac proteins with an average degree of acetylation of 2.
When these 315 proteins were searched in the most comprehensive urinary database (Zhao et al., 2017;  Figure 2A ), 242 were found in 1D group (proteins detectable when separated by 1D LC) and 71 in the 2D and 3D group (2D: high-pH RPLC coupled LC-MS/MS, 3D: GELFrEE/LP-IEF fraction prior to 2D), which were less abundant proteins; 2 were not found in this database.
Analysis of lysine acetylation sites
To examine the relative abundance of the amino acids flanking the acetylation sites, we analyzed the 761 lysineacetylated peptides using Motif-X software. A negatively charged residue, aspartate, at the +1 and +5 positions of acetyllysine was identified ( Figure 2B ). According to previous studies of human lysine acetylation (Zhu et al., 2016) , aspartate was found to be enriched at the −1, −2, and +1 positions of the lysine acetylation site.
To further explore the relationship between the lysine acetylation and protein secondary structures, we performed structural analysis of all acetylated proteins using NetSurfP. Acetylated lysine was found in alpha-helices approximately 8.8% more frequently than the average lysine and in the coil approximately 5.5% less frequently (P<0.01) ( Figure 2C ). Thus, acetylated lysine appears to be enriched in structured regions and depleted in unstructured regions, which is in concordance with previous reports (Choudhary et al., 2009; Kim et al., 2006) .
Functional analysis of lysine-acetylated proteins in urine
Classification analysis of the lysine-acetylated proteins identified in urine was performed using the IPA tool (http:// www.ingenuity.com). This analysis showed that 42.4% of lysine-acetylated proteins were annotated in the cytoplasm, 33.3% in the extracellular space, 18.8% in the plasma membrane, and 5.2% in the nucleus ( Figure 3A) . The proportion of cytoplasm proteins in the lysine acetylome was much higher than that in the whole urinary proteome (17%) (Marimuthu et al., 2011) , while the other proportions of extracellular space or plasma membrane proteins were much lower than that in the whole urinary proteome (38% and 31%) (Marimuthu et al., 2011) . The major types of lysineacetylated proteins were enzymes (enzyme 25.9%, peptidase 11%, kinase 2.3%, phosphatase 1.9%, and transporters 10%) ( Figure 3B ).
Enriched bio functions and diseases were analyzed using the IPA tool. The notable bio functions of these proteins were cell-to-cell signaling and interaction (87 proteins), cell death and survival (118 proteins), cellular growth and proliferation (115 proteins), free radical scavenging (28 proteins), and cellular movement (76 proteins) ( Figure 3C ). The major diseases and disorders associated with these proteins were found to be endocrine system disorders (110 proteins), organismal injury and abnormalities (299 proteins), dermatological diseases and conditions (73 proteins), metabolic disease (95 proteins), and neurological diseases (116 proteins). These results provide valuable information regarding lysine acetylation in the urine and may be useful in biomarker studies for these diseases and disorders.
The main canonical pathways ( Figure 3D ) in which the lysine-acetylated proteins participated, including LXR/RXR activation, acute phase response signaling, and FXR/RXR activation, showed the same rankings in the whole urinary proteome. Among these top 7 networks, three were associated with glucose metabolism, such as glycolysis I, sucrose degradation V (mammalian), and gluconeogenesis I.
DISCUSSION
From the Western Blotting results ( Figure 1B) , acetylation signals are different among these urine samples. This may be caused by protein expressions or acetylated sites. It may also be the result of the combination of the two. Regardless of the reason, different people have different urinary acetylated protein pattern. This is the first proteome-wide characterization of lysine acetylation proteins in normal human urine. A total of 629 acetylation sites on 315 proteins were identified, including some very low-abundance proteins. Enrichment of acetylated peptides vastly reduced the sample complexity and increased the identification dynamic range.
The IPA tool was used to analyse in which pathways these 315 lysine-acetylated proteins were involved. Among the top seven networks, three were associated with glucose metabolism, namely glycolysis I, sucrose degradation V, and gluconeogenesis I ( Figure 3D ). Interestingly, an independent proteomic survey also reported that almost every enzyme in these pathways was acetylated in human liver tissue. Lysine acetylation plays a major role in metabolic regulation (Wang et al., 2010; Zhao et al., 2010) . The IPA analysis reveals that 95 proteins have been associated with metabolic disease and 110 proteins with endocrine system disorders. The urine lysine acetylome may be useful in biomarker studies for endocrine metabolic diseases. Our dataset provides a useful resource for the further discovery of the lysine acetylated proteins as biomarkers in urine. 
MATERIALS & METHODS
Urine sample preparation
The first morning mid-stream urine samples collected from 16 donors (8 males and 8 females), aged 24-40 years (average 30 and 27 years for males and females, respectively) were used for Western blotting analysis. The routine medical examinations were normal, and females who were in menses were excluded. Subjects continued to urinate without interruption, collecting 50 mL of urine in the middle. Next, 20 mL urine samples were filtered through a nitrocellulose membrane, urinary proteins were adsorbed onto the membrane, and the membrane was dried and stored in a vacuum bag as described previously (Jia et al., 2014) . Urinary pro- teins were eluted from the membrane by vortexing, followed by quantification by the Bradford method for western blot analysis.
Pooled first morning mid-stream urine sample (3 males and 3 females, aged 24-30 years) was used for further immune-affinity-based acetyllysine peptide enrichment and LC-MS/MS analysis. Briefly, urine was centrifuged at 3,500 ×g for 30 min. After discarding the debris, the supernatant was centrifuged at 12,000×g for 30 min. After the removal of precipitates, urinary proteins in the supernatant were precipitated with acetone and re-dissolved in lysis buffer (7 M urea, 2 M thiourea, 120 mmol L −1 dithiothreitol, and 40 mmol L −1 Tris), and then quantified by the Bradford method for immune-affinity enrichment and LC-MS/MS analysis.
Western blot analysis
Urinary proteins from each sample (30 μg, n=16) were separated by 12% SDS-PAGE and transferred to a polyvinylidene difluoride (PVDF) membrane. After blocking in TBST buffer (1× TBS containing 0. 1% Tween 20) with 5% (w/v) skimmed milk for 40 min at room temperature, the membranes were incubated with diluted primary antibodies (dilution 1:1000) (PTM Biolabs, Chicago, IL, USA) at 4°C with gentle shaking overnight. Next, the membrane was probed with secondary antibodies (dilution 1:5000) coupled to horseradish peroxidase. Signals were revealed by enhanced chemiluminescence, and the results were scanned and analyzed using an Image Quant 400TM Imager (GE Healthcare, Little Chalfont, UK). Finally, the membrane was stained with Coomassie Brilliant Blue.
Protein digestion
Urinary proteins (5 mg) were used for digestion, the protein solution was reduced with 10 mmol L −1 DTT (dithiothreitol)
for 1 h at 37°C and alkylated with 20 mmol L −1 IAA (iodoacetamide) for 45 min at room temperature in the dark. For trypsin digestion, the protein sample was diluted by adding 100 mmol L −1 ammonium bicarbonate to make the urea concentration less than 2 mol L −1 . Finally, trypsin was added at a 1:50 trypsin-to-protein mass ratio for the first digestion overnight and 1:100 trypsin-to-protein mass ratio for the second 4-h digestion.
Off-line high-pH HPLC separation
Tryptic peptides (2 mg) was then fractionated by high pH reverse-phase HPLC using an Agilent 300Extend C18 column (5 μm particles, 4.6 mm ID, 250 mm length, Santa Clara, CA, USA). Briefly, peptides were first separated over a gradient of 2%-60% acetonitrile in 10 mmol L −1 ammo-nium bicarbonate, pH 10.0 for 80 min into 80 fractions. Next, the peptides were combined into 7 fractions and dried by vacuum centrifugation. 
Enrichment of lysine-acetylated peptides
LC-MS/MS analysis
The lyophilized peptides were re-suspended in 0.1% formic acid and subjected to chromatography using an EASY-nLC 1000 UPLC system (Thermo Scientific, Waltham, MA, USA). The peptides were separated on a reversed-phase analytical column (50 µm×150 mm, 2 µm, C18, 100 Å, Thermo Scientific). Elution was performed over a gradient of 7%-35% buffer B (0.1% formic acid in 98% ACN; flow rate, 0.3 μL min −1 ) for 40 min. A Q ExactiveTM Plus mass spectrometer (Thermo Scientific) was used to analyze the fractions. The MS data were acquired using the high-sensitivity mode with the following parameters: 20 data-dependent MS/MS scans per full scan; full MS scans acquired using a 350-1800 m/z range at a resolution of 70,000, AGC set to 2e6, maximum injection time 50 ms; MS/MS scans acquired at a resolution of 17,500, AGC set to 1e5, maximum injection time 100 ms, isolation window set to 0.7, dynamic exclusion (exclusion duration 30 s).
Data processing
The MS raw data were processed using the PEAKS Studio (version 7.5, Bioinformatics Solution Inc., Waterloo, Canada). High-quality de novo sequence tags were then used by PEAKS DB (Zhang et al., 2012) to search the human proteome database (UniProtKB/Swiss-Prot release 2014-01-10). The fasta file contained 20120 protein sequences. A mass tolerance of 10 ppm and 0.02 Da was set for the precursor ions and fragment ions, respectively. Cysteine carbamidomethylation was set as fixed modification, oxidation (M), protein N-terminal and lysine acetylation as variable modifications. Trypsin allowing 3 missed cleavages was chosen as the enzyme. A decoy database was also searched to calculate the false-discovery rate (FDR) using the decoyfusion method. Result filtration parameters were: peptidespectrum matches FDR<0.1%; Peptide −10 lgP≥27.5 (FDR 0.2%); Protein −10 lgP≥28 (FDR 0.0%), and proteins unique peptides≥1; AScore≥59 considered as a confident Kac site.
Motif and secondary structure analysis
Software motif-x was used to analyze the model of sequences with amino acids in specific positions of acetylated lysine-13mers (6 amino acids upstream and downstream of the acetylation site) in all protein sequences (Chou and Schwartz, 2011) . The IPI human proteome was used as an extension database, while other parameters were set to default values. The local secondary structures of lysine-acetylated proteins were predicted by NetSurfP (Petersen et al., 2009) .
Protein networks and functional analysis
All identified lysine-acetylated urinary proteins were subjected to network and functional analyses using Ingenuity Pathway Analysis (IPA) version 9.0 (http://www.ingenuity. com).
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